137 related articles for article (PubMed ID: 28703412)
1. Fumarate hydratase expression is retained in atypical intradermal smooth muscle neoplasms and cutaneous leiomyosarcomas.
Coy S; Doyle LA
Histopathology; 2017 Dec; 71(6):1023-1025. PubMed ID: 28703412
[No Abstract] [Full Text] [Related]
2. Immunoexpression of p53 in cutaneous and subcutaneous leiomyosarcomas.
Fernandez-Flores A; Monteagudo C
Ann Diagn Pathol; 2016 Oct; 24():25-9. PubMed ID: 27649950
[TBL] [Abstract][Full Text] [Related]
3. Loss of Fumarate Hydratase and Aberrant Protein Succination Detected With S-(2-Succino)-Cysteine Staining to Identify Patients With Multiple Cutaneous and Uterine Leiomyomatosis and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome.
Llamas-Velasco M; Requena L; Adam J; Frizzell N; Hartmann A; Mentzel T
Am J Dermatopathol; 2016 Dec; 38(12):887-891. PubMed ID: 27097334
[TBL] [Abstract][Full Text] [Related]
4. [Atypical leiomyoma in a patient with cutaneous leiomyomatosis and mutation of the enzyme fumarate hydratase].
Calderón-Komáromy A; Arias-Palomo D; Tardío JC; Freites-Martínez A; Borbujo J
Invest Clin; 2016 Mar; 57(1):59-65. PubMed ID: 27382802
[TBL] [Abstract][Full Text] [Related]
5. Atypical intradermal smooth muscle neoplasms (formerly cutaneous leiomyosarcomas): case series, immunohistochemical profile and review of the literature.
Hall BJ; Grossmann AH; Webber NP; Ward RA; Tripp SR; Rosenthal HG; Florell SR; Randall RL; Cockerell CJ; Layfield LJ; Liu T
Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):132-8. PubMed ID: 22820664
[TBL] [Abstract][Full Text] [Related]
6. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers.
Muller M; Ferlicot S; Guillaud-Bataille M; Le Teuff G; Genestie C; Deveaux S; Slama A; Poulalhon N; Escudier B; Albiges L; Soufir N; Avril MF; Gardie B; Saldana C; Allory Y; Gimenez-Roqueplo AP; Bressac-de Paillerets B; Richard S; Benusiglio PR
Clin Genet; 2017 Dec; 92(6):606-615. PubMed ID: 28300276
[TBL] [Abstract][Full Text] [Related]
7. Novel fumarate hydratase mutation in a family with atypical uterine leiomyomas and hereditary leiomyomatosis and renal cell cancer.
Wheeler KC; Warr DJ; Warsetsky SI; Barmat LI
Fertil Steril; 2016 Jan; 105(1):144-8. PubMed ID: 26493120
[TBL] [Abstract][Full Text] [Related]
8. Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients.
Joseph NM; Solomon DA; Frizzell N; Rabban JT; Zaloudek C; Garg K
Am J Surg Pathol; 2015 Nov; 39(11):1529-39. PubMed ID: 26457356
[TBL] [Abstract][Full Text] [Related]
9. No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas.
Barker KT; Spendlove HE; Banu NS; Bridge JA; Fisher C; Shipley J; Garrett M; Manyonda I; Houlston RS
Cancer Lett; 2006 Apr; 235(1):136-40. PubMed ID: 15949892
[TBL] [Abstract][Full Text] [Related]
10. Fumarate Hydratase-deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings.
Harrison WJ; Andrici J; Maclean F; Madadi-Ghahan R; Farzin M; Sioson L; Toon CW; Clarkson A; Watson N; Pickett J; Field M; Crook A; Tucker K; Goodwin A; Anderson L; Srinivasan B; Grossmann P; Martinek P; Ondič O; Hes O; Trpkov K; Clifton-Bligh RJ; Dwight T; Gill AJ
Am J Surg Pathol; 2016 May; 40(5):599-607. PubMed ID: 26574848
[TBL] [Abstract][Full Text] [Related]
11. Fumarate hydratase immunohistochemical staining may help to identify patients with multiple cutaneous and uterine leiomyomatosis (MCUL) and hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome.
Llamas-Velasco M; Requena L; Kutzner H; Schärer L; Rütten A; Hantschke M; Paredes BE; Mentzel T
J Cutan Pathol; 2014 Nov; 41(11):859-65. PubMed ID: 25292446
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous leiomyosarcoma with myxoid alteration arising in a setting of multiple cutaneous smooth muscle neoplasms.
Utikal J; Haus G; Poenitz N; Koenen W; Back W; Dippel E; Gratchev A; Goerdt S
J Cutan Pathol; 2006 Sep; 33 Suppl 2():20-3. PubMed ID: 16972948
[TBL] [Abstract][Full Text] [Related]
13. Smooth Muscle Tumors of the Female Genital Tract.
Devereaux KA; Schoolmeester JK
Surg Pathol Clin; 2019 Jun; 12(2):397-455. PubMed ID: 31097110
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
15. Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families.
Kiuru M; Lehtonen R; Arola J; Salovaara R; Järvinen H; Aittomäki K; Sjöberg J; Visakorpi T; Knuutila S; Isola J; Delahunt B; Herva R; Launonen V; Karhu A; Aaltonen LA
Cancer Res; 2002 Aug; 62(16):4554-7. PubMed ID: 12183404
[TBL] [Abstract][Full Text] [Related]
16. Tumors with smooth muscle differentiation.
Spencer JM; Amonette RA
Dermatol Surg; 1996 Sep; 22(9):761-8. PubMed ID: 8874523
[TBL] [Abstract][Full Text] [Related]
17. [Atypical intradermal smooth-muscle neoplasm].
Attencourt C; Thuillier D; Lombart F; Petit T
Ann Dermatol Venereol; 2017; 144(6-7):443-445. PubMed ID: 28242098
[TBL] [Abstract][Full Text] [Related]
18. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
19. Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous "leiomyosarcoma".
Kraft S; Fletcher CD
Am J Surg Pathol; 2011 Apr; 35(4):599-607. PubMed ID: 21358302
[TBL] [Abstract][Full Text] [Related]
20. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]